Three deaths have been reported after Pharmac forced patients using lamotrigine to switch brands. Three deaths have been reported to the Centre for Adverse Reactions Monitoring (CARM) after Pharmac forced patients using the medicine lamotrigine to switch brands. Medsafe announced on its website today that three deaths had now been reported in relation to the switch. READ MORE:* Feilding epilepsy sufferer feared increased seizures following Pharmac's drug brand switch* Seizures, driving stand-downs as Pharmac pulls epilepsy drug fundingCARM went on to caution it was not yet known whether the brand switch was the cause of any of the deaths. Medsafe had warned Pharmac not to make the drug switch, but the drug buying agency pressed ahead.

Source: Stuff November 12, 2019 05:10 UTC